COMMUNIQUÉS West-GlobeNewswire

Women’s Health Collective Canada Announces Vital Talks Event on Menstruation and Lifelong Hormonal Health, Presented by Vichy Laboratoires
28/01/2026
From menstrual cycles to menopause and beyond – experts explore how hormones shape health at every stage of life TORONTO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Women’s Health Collective Canada is pleased to announce the [...]
MEDVI Quad Prescription Information Updated as Consumer Interest in Prescription Erectile Dysfunction Treatment Access Through Telehealth Platforms Grows in 2026
28/01/2026
An informational overview examining category context, publicly available service disclosures, and what consumers often consider when researching prescription erectile dysfunction treatment access through telehealth [...]
GUERBET : Karim Boussebaa nommé Directeur général
28/01/2026
Karim Boussebaa nommé Directeur général de Guerbet Villepinte, le 28 janvier 2026 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, annonce la nomination [...]
NADP Foundation Announces 2026 Grants
28/01/2026
DALLAS, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The National Association of Dental Plans (NADP) Foundation is pleased to announce the recipients of its 2026 grant awards, supporting innovative projects that improve access to [...]
Guerbet: Karim Boussebaa appointed Chief Executive Officer
28/01/2026
Karim Boussebaa Appointed Chief Executive Officer of Guerbet Villepinte, January 28, 2026: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, announces the appointment [...]
Siren Biotechnology Announces FDA Clearance of First IND, Advancing Company to Clinical Stage
28/01/2026
SAN FRANCISCO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for cancer, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s [...]
Memorial Şişli Hospital Earns EARL “Theranostics Center of Excellence” for Nuclear Oncology Treatments
28/01/2026
ISTANBUL, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Memorial Şişli Hospital’s (part of Memorial Hospitals Group ) Nuclear Medicine Department, Theranostics Unit has successfully completed the evaluation process under the [...]
ENvue Medical Signs Strategic Partnership Agreement with U-Deliver for U.S. Distribution of Over-the-Counter Reusable ENFit Syringe Line
28/01/2026
Distribution agreement leverages U-Deliver’s digital and wholesale channels to expand access to ENvue’s recently launched ENFit Syringes across non-acute care channels TYLER, Texas, Jan. 28, 2026 (GLOBE NEWSWIRE) -- [...]
COUR Pharma Publishes Peer-Reviewed Data in Science Advances
28/01/2026
Paper defines the mechanism by which COUR Nanoparticles induce antigen-specific immune tolerance CHICAGO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing ﬁrst-in-class, [...]
Confluent Medical Debuts Filmcast Select™ to Enable Tailored Performance in PTFE and Polyimide Tubing
28/01/2026
New Filmcast Select™ Program Allows OEMs To Tailor Flexibility, Strength, And Durability In PTFE And Polyimide Tubing To Meet The Demands Of Next-Generation Minimally Invasive Devices CHATTANOOGA, Tenn., Jan. 28, 2026 ( [...]
CytoMed Therapeutics Refutes Misleading Claims and Reaffirms Clinical Progress
28/01/2026
SINGAPORE, Jan. 28, 2026 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary [...]
Medline to report fourth quarter and full year 2025 results on February 25, 2026
28/01/2026
NORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026. A [...]
Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease
28/01/2026
• Support from The Michael J. Fox Foundation for Parkinson’s Research to advance critical research into Parkinson’s disease biology • Nautilus’ development of a single-molecule assay for measuring alpha-synuclein [...]
Bay Alarm Medical Celebrates 16,500 5-Star Google Reviews, Reinforcing Role as Best Medical Alert System
28/01/2026
Milestone underscores the company’s commitment to safety, service, and dependable emergency response for aging adults across the U.S. Concord, CA, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Bay Alarm Medical , a nationwide [...]
Aeroflow Health Partners with Priority Partners, owned by Johns Hopkins Health Plans and the Maryland Community Health System, To Expand DME Access to Maryland Medicaid Members
28/01/2026
Medicaid members under Priority Partners will now have access to critical care supplies such as breast pumps, diapers, and CPAPs ASHEVILLE, N.C., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Aeroflow Health , a pioneering [...]
Cannara Announces Conditional Approval to List on the Toronto Stock Exchange
28/01/2026
MONTREAL, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara ”, “the Company ”, “ us ” or “ we ”) ( TSXV: LOVE ) ( OTCQX: LOVFF ) ( FRA: 8CB0 ), a vertically integrated producer of premium-grade cannabis [...]
Genvor Appoints Dr. George Stavrides as Executive Vice President, Business Development & Commercialization
28/01/2026
Agricultural biologicals leader brings 15+ years of global R&D and product management experience from Syngenta to accelerate Genvor’s strategic partnerships and market expansion Woodland, CA, Jan. 28, 2026 (GLOBE [...]
Bexorg Awarded Grant from The Michael J. Fox Foundation to Identify Translational Biomarkers for TRPML1-Targeted Parkinson’s Disease Therapies
28/01/2026
- TRPML1 is a promising target 1 for Parkinson’s disease treatments and identifying translational biomarkers will help confirm target engagement in clinical studies - Bexorg will leverage its postmortem whole-human [...]
SCYNEXIS Announces Presentations Highlighting the Potent Antifungal Activity of its Second-Generation Fungerp, SCY-247 Against Drug-Resistant Fungi, at the Inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)
28/01/2026
This cross-disciplinary meeting highlights the latest discoveries, technologies and translational strategies driving the next generation of antimicrobial solutions JERSEY CITY, N.J., Jan. 28, 2026 (GLOBE NEWSWIRE) -- [...]

Pages